11 completed, 1 terminated. 7 Phase 1, 5 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 6, Terminated 1 |
| Phase 2 | 5 | Completed 5 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow MediGene: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating the Pharmacokinetic Profile of Novel Formulations of RHUDEX® RhuDex - Formulation Finding | Phase 1 | Completed | MediGene | 12 | 2011-12-01 | 2012-06-21 |
| Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers Veregen, Green Tea - Anogenital Warts | Phase 1 | Completed | MediGene | 30 | 2011-12-01 | 2012-04-19 |
| Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage Polyphenon E (Veregen) 15% ointment, Green Tea Beverage with defined catechin content - Genital Warts, Perianal Warts | Phase 4 | Completed | MediGene | 43 | 2010-01-01 | 2010-09-08 |
| Study Evaluating the Pharmacokinetic Profile of RhuDex® in a Tablet Formulation RhuDex® - Pharmacokinetics | Phase 1 | Terminated | MediGene | 12 | 2008-05-01 | 2010-03-24 |
| A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases EndoTAG®-1 - Liver Cancer, Neoplasm Metastasis | Phase 2 | Completed | MediGene | 20 | 2007-11-01 | 2010-02-09 |
| Phase-I Study Evaluating the Pharmacokinetic Profile of RhuDex® RhuDex® - Pharmacokinetics | Phase 1 | Completed | MediGene | 10 | 2007-09-01 | 2008-07-16 |
| EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients EndoTAG-1 + paclitaxel, EndoTAG-1, Paclitaxel - Breast Neoplasms | Phase 2 | Completed | MediGene | 143 | 2007-01-01 | 2012-01-05 |
| EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas Gemcitabine alone, EndoTAG-1 and Gemcitabine - Adenocarcinoma, Metastasis | Phase 2 | Completed | MediGene | 212 | 2005-09-01 | 2008-11-14 |
| G207 Followed by Radiation Therapy in Malignant Glioma G207 - Malignant Glioma | Phase 1 | Completed | MediGene | 9 | 2005-05-01 | 2008-12-16 |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver NV1020 - Colorectal Cancer, Liver Neoplasms | Phase 1 / Phase 2 | Completed | MediGene | 32 | 2004-07-01 | 2018-04-24 |
| Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts Polyphenon E Ointment 10%, Polyphenon E Ointment 15% - Condylomata Acuminata | Phase 3 | Completed | MediGene | 480 | 2003-07-01 | 2007-03-21 |
| Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer G207, an oncolytic virus - Glioma, Astrocytoma | Phase 1 / Phase 2 | Completed | MediGene | 65 | 2001-12-01 | 2005-06-24 |
Condylomata Acuminata (3) · Neoplasm Metastasis (3) · Astrocytoma (2) · Brain Neoplasms (2) · Glioblastoma (2) · Glioma (2) · Liver Neoplasms (2) · Recurrence (2) · Adenocarcinoma (1) · Arthritis, Rheumatoid (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Gliosarcoma (1)
MBT-0206 (2) · green tea extract polyphenone E (2) · Gemcitabine (1) · Ointments (1) · Paclitaxel (1) · Tea (1) · polyphenon E (1)
Germany (3) · United Kingdom (3) · United States (3) · Romania (2) · Ukraine (2) · Argentina (1) · Belgium (1) · Chile (1) · Colombia (1) · Czechia (1) · France (1) · Hungary (1) · India (1) · Mexico (1) · Peru (1)
Ahmad Awada, Dr. (1) · Axel Mescheder, M.D. (1) · Frank Wagner, Md, PD (1) · Hoda Tawfik, PhD (1) · Karl R. Beutner, M.D., Ph.D. (1) · Klaus Mross, PD (1) · Stephen Freestone, MD (1) · Stuart Mair, MBChB, DROCG,DCPSA (1)